Voloridge Investment Management’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-53,308
| Closed | -$13.9M | – | 1238 |
|
|
2025
Q3 | $13.9M | Sell |
53,308
-295,727
| -85% | -$77.8M | 0.05% | 447 |
|
|
2025
Q2 | $85.3M | Sell |
349,035
-123,288
| -26% | -$30.7M | 0.31% | 70 |
|
|
2025
Q1 | $125M | Buy |
472,323
+171,630
| +57% | +$46.4M | 0.46% | 36 |
|
|
2024
Q4 | $76.3M | Sell |
300,693
-227,146
| -43% | -$60.9M | 0.27% | 102 |
|
|
2024
Q3 | $167M | Buy |
527,839
+225,024
| +74% | +$80.1M | 0.61% | 18 |
|
|
2024
Q2 | $113M | Sell |
302,815
-521,884
| -63% | -$176M | 0.42% | 48 |
|
|
2024
Q1 | $286M | Buy |
824,699
+546,817
| +197% | +$207M | 1.04% | 6 |
|
|
2023
Q4 | $127M | Buy |
277,882
+190,103
| +217% | +$93.7M | 0.5% | 41 |
|
|
2023
Q3 | $42.7M | Buy |
+87,779
| New | +$41.3M | 0.21% | 125 |
|
|
2023
Q1 | – | Sell |
-99,342
| Closed | -$50.9M | – | 1462 |
|
|
2022
Q4 | $50.9M | Buy |
99,342
+84,883
| +587% | +$44.6M | 0.28% | 79 |
|
|
2022
Q3 | $7.01M | Buy |
+14,459
| New | +$7.03M | 0.04% | 544 |
|
|
2022
Q2 | – | Sell |
-43,304
| Closed | -$18.8M | – | 1524 |
|
|
2022
Q1 | $18.8M | Buy |
43,304
+21,860
| +102% | +$9.14M | 0.11% | 263 |
|
|
2021
Q4 | $9.95M | Sell |
21,444
-66,772
| -76% | -$29.5M | 0.05% | 471 |
|
|
2021
Q3 | $34.3M | Sell |
88,216
-43,954
| -33% | -$18.7M | 0.22% | 90 |
|
|
2021
Q2 | $58.5M | Sell |
132,170
-9,746
| -7% | -$4.26M | 0.41% | 28 |
|
|
2021
Q1 | $59.5M | Buy |
+141,916
| New | +$56.7M | 0.43% | 36 |
|
|
2020
Q3 | – | Sell |
-11,136
| Closed | -$4.32M | – | 1347 |
|
|
2020
Q2 | $4.32M | Sell |
11,136
-9,777
| -47% | -$3.66M | 0.05% | 388 |
|
|
2020
Q1 | $6.57M | Sell |
20,913
-31,428
| -60% | -$10.6M | 0.19% | 125 |
|
|
2019
Q4 | $19.2M | Buy |
52,341
+30,594
| +141% | +$9.7M | 0.37% | 46 |
|
|
2019
Q3 | $5.56M | Buy |
+21,747
| New | +$6.1M | 0.1% | 238 |
|
|
2019
Q2 | – | Sell |
-65,443
| Closed | -$17.4M | – | 893 |
|
|
2019
Q1 | $17.4M | Buy |
65,443
+20,832
| +47% | +$6M | 0.52% | 39 |
|
|
2018
Q4 | $12.8M | Sell |
44,611
-24,614
| -36% | -$7.8M | 0.58% | 42 |
|
|
2018
Q3 | $23.4M | Buy |
69,225
+61,531
| +800% | +$20M | 0.51% | 62 |
|
|
2018
Q2 | $2.29M | Buy |
7,694
+5,823
| +311% | +$1.71M | 0.06% | 262 |
|
|
2018
Q1 | $503K | Buy |
+1,871
| New | +$507K | 0.01% | 416 |
|
|
2017
Q4 | – | Sell |
-210,938
| Closed | -$51.4M | – | 536 |
|
|
2017
Q3 | $51.4M | Buy |
210,938
+20,490
| +11% | +$5.02M | 1.15% | 12 |
|
|
2017
Q2 | $45.8M | Buy |
190,448
+25,536
| +15% | +$5.78M | 1.14% | 18 |
|
|
2017
Q1 | $34M | Buy |
164,912
+112,754
| +216% | +$23.3M | 0.83% | 22 |
|
|
2016
Q4 | $10.6M | Buy |
+52,158
| New | +$9.95M | 0.23% | 113 |
|
|
2015
Q2 | – | Sell |
-67,228
| Closed | -$12M | – | 337 |
|
|
2015
Q1 | $12M | Buy |
+67,228
| New | +$10.6M | 0.58% | 51 |
|
|
2014
Q2 | – | Sell |
-113,504
| Closed | -$12.8M | – | 102 |
|
|
2014
Q1 | $12.8M | Buy |
113,504
+46,072
| +68% | +$4.8M | 1.82% | 17 |
|
|
2013
Q4 | $6.96M | Buy |
+67,432
| New | +$6.61M | 1.33% | 26 |
|
Other funds holding HUM
Voloridge Investment Management's HUM Position: Q4 2025 in Review
Voloridge Investment Management sold out of Humana (HUM) in Q4 2025, closing a stake of 53,308 shares — an estimated $13.9M sold.
Voloridge Investment Management first reported a position in HUM in Q4 2013 and held it in 32 quarters. The position peaked at $286M in Q1 2024. 862 funds tracked by Wall St. Rank hold HUM as of Q4 2025.
- Voloridge Investment Management reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
- Voloridge Investment Management sold 53,308 Humana shares in Q4 2025, an estimated $13.9M.
- Voloridge Investment Management first reported a position in Humana in Q4 2013 and held it in 32 quarters.
- Voloridge Investment Management's Humana position peaked at $286M in Q1 2024.
- 862 funds tracked by Wall St. Rank held Humana as of Q4 2025.
Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.